Gangtong Medical plans to launch a restricted stock incentive plan in 2025
I'm PortAI, I can summarize articles.
Gangtong Medical released a draft of the 2025 restricted stock incentive plan, proposing to grant 1.23 million restricted shares, accounting for 1.23% of the company's total share capital. The grant price is set at 10.13 yuan per share, and the plan has a maximum validity period of 48 months
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments